8 Nov 2012

Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012 (Euro Surveill., abstract, edited)

[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 17, Issue 45, 08 November 2012

Rapid communications

Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012

C Flateau ()1, F Janvier2, H Delacour2, S Males3, C Ficko1, D Andriamanantena1, K Jeannot4, A Mérens2, C Rapp1

  1. Service des maladies infectieuses et tropicales, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
  2. Service de microbiologie-hygiène, Hôpital d’instruction des armées Bégin, Saint-Mandé, France
  3. Service de médecine et maladies infectieuses, Hôpital Henri Duffaut, Avignon, France
  4. Centre National de la Résistance aux Antibiotiques, Laboratoire de Bactériologie, Hôpital Jean Minjoz, Besançon, France

Citation style for this article: Flateau C, Janvier F, Delacour H, Males S, Ficko C, Andriamanantena D, Jeannot K, Mérens A, Rapp C. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill. 2012;17(45):pii=20311. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20311
Date of submission: 29 October 2012


We describe the first isolation in France of a New-Delhi metallo-beta-lactamase-1 (NDM-1) producing Pseudomonas aeruginosa. In March 2012, a patient with history of prior hospitalisation in Serbia was diagnosed in France with acute pyelonephritis due to NDM-1 producing P. aeruginosa. Clinical and microbiological cure was obtained under appropriate antibiotic treatment. Two months later, she presented with a recurrence due to the same bacteria, with a favourable evolution. During both hospitalisations, contact isolation precautions were implemented and no cross-transmission was observed.

-

-------